Skip to content
Medical Health Aged Care

Arthritis Australia welcomes start of 60-day scripts

Arthritis Australia 2 mins read


Embargoed 00.01 hrs Friday 1st September 2023


Arthritis Australia welcomes

start of 60-day scripts


[Sydney, Australia] Arthritis Australia has welcomed the start of access to 60-day scripts, with the first tranche of commonly used medicines able to be prescribed from September 1 2023.

“From today we will see the cost of many common medicines halved for people with chronic disease. This will provide much needed cost of living relief for many who have waited long enough for cheaper medicines,” said Arthritis Australia CEO Jonathan Smithers.

“This reform is a no-brainer when you consider that 60 and even 90-day scripts have been available to people in similar countries for years now. Living with a chronic condition, such as arthritis, is incredibly expensive, and we never want to see people forced to choose between paying for their medicines or keeping the lights on,” he added.

The measures will allow a 60-day supply of some arthritis medicines to be dispensed, with consumers potentially saving hundreds of dollars a year. It will also allow doctors to provide one prescription for 12 months, with appropriate patients, reducing the number of appointments required and freeing up GP appointments for those who really need them.


About Arthritis Australia

Arthritis Australia is the peak national body for arthritis, advocating on behalf of over 3.6 million Australians living with arthritis, and working with many other arthritis organisations to deliver information and support to people living with more than 100 types of arthritis and musculoskeletal conditions. We are a leading non-government funder of arthritis research in Australia and advocate for policies, programs and funding initiatives that will improve the health and wellbeing of people living with arthritis.

For more information visit:

-- ends --


Issued by Cube on behalf of Arthritis Australia.  For more information, please contact:

Anne-Marie Sparrow on 0417 421 560.


Available for interview: Jonathan Smithers, CEO, Arthritis Australia

More from this category

  • Medical Health Aged Care
  • 29/05/2024
  • 11:54

Long-term prescription opioid use after hospital declining: study

UNSW Sydney medical researchers have shed light on post-hospital prescription opioid use. A large, linked data study has detailed the scale of prescription opioid…

  • Contains:
  • Medical Health Aged Care
  • 29/05/2024
  • 11:45
Cleo Diagnostics Limited ASX.COV

Cleo’s Ovarian Cancer Blood Test Outperforms Current Clinical Benchmark

Highlights A benchmarking study comparing CLEO’s ovarian cancer blood test against ultrasound has been published in scientific journal “Cancers” The study confirmed that CLEO’s initial test for the surgical triage market:– Significantly outperforms current clinical workflows that use CA125 and ultrasound to predict malignancy;– Correctly detected 90% of early-stage cancers compared to only 50% using standard workflows; and– Can be easily adopted for use into clinical practice. The superior performance of CLEO’s test now compared to all current routine clinical tools shows the significant global potential for the test in clinical decision making prior to surgical intervention. MELBOURNE, AUSTRALIA, 29…

  • Medical Health Aged Care
  • 29/05/2024
  • 05:00
Dementia Australia

De-escalation VR training for behavioural emergencies set to revolutionise dementia education – on show today at Adelaide Convention Centre

In Adelaide today Dementia Australia unveiled D-Esc, a new innovative virtual reality (VR) training workshop for de-escalating a behavioural emergency in a care setting. D-Esc provides an immersive simulation, designed for frontline and health care professionals, to adopt an interactive approach to de-escalation training. Participants will build empathy and understanding towards people with dementia, with the aim to reduce the use of restrictive practices and the number and severity of dangerous incidents in care. Dementia Australia Executive Director Services, Advocacy and Research Dr Kaele Stokes said this new workshop provides training which is integral to the safety and professional development…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.